Glutathione (GSH) enhancement in a concentration-dependent manner (millimolar concentrations) in DC is directly associated with IL-12 production, which in turn favours a Th1 CD4+ T cell response, resulting in the production of IL-2, IL-12, and IFN-
About 44% of users in the study mentioned at least one side effect, most commonly gastrointestinal problems
Therefore, to further dissociate the effects of GSH and NRF2 on lipid abundance and assess if NRF2 activation alone mimics the effects of liver-specific Gclc deletion, we treated Gclc WT mice with CDDO-methyl (CDDO-Me), a form of bardoxolone with increased bioavailability
No mortality was observed during the 14-week study period, demonstrating the safety of TB001 with current therapeutic dose
Guidelines consistently recommend enhanced fasting protocols, gastric ultrasound assessment, and modified anaesthetic techniques as alternatives to medication cessation [49]